An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: A pooled analysis from the SPIRIT II and SPIRIT III trials

Antonio L. Bartorelli, Patrick W. Serruys, Karine Miquel-Hébert, Shui Yu, Wes Pierson, Gregg W. Stone

Research output: Contribution to journalArticle


Objectives: To evaluate the safety and efficacy of the XIENCE V everolimus-eluting stent compared to the TAXUS paclitaxel-eluting stent in small vessels. Backgroud: The XIENCE V everolimus-eluting stent (EES) has been shown to improve angiographic and clinical outcomes after percutaneous myocardial revascularization, but its performance in small coronary arteries has not been investigated. Methods: In this pooled analysis, we studied a cohort of 541 patients with small coronary vessels (reference diameter

Original languageEnglish
Pages (from-to)60-66
Number of pages7
JournalCatheterization and Cardiovascular Interventions
Issue number1
Publication statusPublished - Jul 1 2010



  • Coronary arteries
  • Drug-eluting stents
  • Lumen loss
  • Small vessels

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this